Home › Companies › EMERGENT BIOSOLUTIONS INC. › 2023-2024

EMERGENT BIOSOLUTIONS INC. 2023-2024 Proxy Voting Records

Compiled from SEC Form N-PX filings and EMERGENT BIOSOLUTIONS INC.’s Form 8-K, filed May 29, 2024 (Item 5.07 on EDGAR). Page generated October 13, 2026.

  • 6Reported items
  • 155Asset managers
  • 934Fund votes
  • May 23, 2024Meeting date

Results at a glance

Meeting of May 23, 2024: 6 items on EMERGENT BIOSOLUTIONS INC.’s Form 8-K, filed May 29, 2024: 3 elected · 3 approved.

Material dissent

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided · This season’s results screens

Proxy season: 2023-2024 2024-2025 2025-2026

Explore EMERGENT BIOSOLUTIONS INC. in the interactive database Compare manager voting policies

Official 2023-2024 meeting results reported by EMERGENT BIOSOLUTIONS INC.

These tallies are EMERGENT BIOSOLUTIONS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 29, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

EMERGENT BIOSOLUTIONS INC. — official shareholder meeting results, meeting held May 23, 2024
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Donald DeGolyer 23,613,429---- 906,65513,259,108 96%Elected—
Elect Director: Neal Fowler 23,476,806---- 1,043,27813,259,108 96%Elected—
Elect Director: Marvin White 15,374,307---- 9,145,77713,259,108 63%Elected—
2. Approved 36,285,3911,370,317123,484 ---- 96%Approved—
3. Approved 23,648,074693,485178,525 --13,259,108 97%Approved—
4. Approved 19,209,8345,137,504172,746 --13,259,108 79%Approved—

Source: EMERGENT BIOSOLUTIONS INC., Form 8-K, filed with the SEC on May 29, 2024 — read the filing on EDGAR.

How asset managers voted at the EMERGENT BIOSOLUTIONS INC. 2023-2024 meeting

Each item below shows how the 155 asset managers that disclosed a EMERGENT BIOSOLUTIONS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of EMERGENT BIOSOLUTIONS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. Elect Director: Donald DeGolyer

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 4 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%
FOR: 23,613,429WITHHELD: 906,655
Details: description as filed, official tally, votes by 47 asset managers

Description as filed by funds: To elect three Class III directors to hold office for a term expiring at our 2027 Annual Meeting of Stockholders, each to serve and until their respective successors are duly elected and qualified: Donald DeGolyer

EMERGENT BIOSOLUTIONS INC.’s own tally for this item (“Elect Director: Donald DeGolyer”): 23,613,429 for, 906,655 withheld, per its Form 8-K filed May 29, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “All director nominees were elected and qualified.”
Support: 96% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 47 asset managers below reported 12,157,232 for, 13,396 withheld.

FOR
FOR: 12,157,232WITHHOLD: 13,396
Largest asset managers voting on “To elect three Class III directors to hold office for a term expiring at our 2027 Annual Meeting of Stockholde” at EMERGENT BIOSOLUTIONS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Charles Schwab3,837,5400 00For
Vanguard3,245,0170 00For
BlackRock2,798,7020 00For
BRIDGEWAY FUNDS INC546,2330 00For
Invesco546,1250 00For
American Century174,5480 00For
SEI117,7240 00For
Capitol Series Trust100,9000 00For
TARGET PORTFOLIO TRUST92,9000 00For
QUANTITATIVE MASTER SERIES LLC86,3970 00For
MASTER INVESTMENT PORTFOLIO86,3000 00For
State Street75,1580 00For
Equitable63,5330 00For
Prudential/PGIM62,1000 00For
Lincoln Financial50,3550 00For
AQR42,6730 00For
Northern Trust33,0000 00For
Fidelity27,0230 00For
AIG/SunAmerica25,6290 00For
Bridge Builder Trust21,1730 00For
Pacific Life20,0720 00For
New York Life14,0590 00For
Amplify ETF Trust00 013,396Withhold
John Hancock13,2530 00For
Blackstone Alternative Investment Funds12,0000 00For

Showing the 25 largest of 47 asset managers. See all 47 in the interactive database.

2. Elect Director: Marvin White

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 4 wordings of this item as funds reported it.

63% Majority: yes · of votes cast

FOR 63%WITHHELD
FOR: 15,374,307WITHHELD: 9,145,777
Details: description as filed, official tally, votes by 47 asset managers

Description as filed by funds: To elect three Class III directors to hold office for a term expiring at our 2027 Annual Meeting of Stockholders, each to serve and until their respective successors are duly elected and qualified: Marvin White

EMERGENT BIOSOLUTIONS INC.’s own tally for this item (“Elect Director: Marvin White”): 15,374,307 for, 9,145,777 withheld, per its Form 8-K filed May 29, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “All director nominees were elected and qualified.”
Support: 63% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 47 asset managers below reported 7,507,932 for, 4,662,696 withheld.

FORWITHHOLD
FOR: 7,507,932WITHHOLD: 4,662,696
Largest asset managers voting on “To elect three Class III directors to hold office for a term expiring at our 2027 Annual Meeting of Stockholde” at EMERGENT BIOSOLUTIONS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Charles Schwab00 03,837,540Withhold
Vanguard3,245,0170 00For
BlackRock2,798,7020 00For
BRIDGEWAY FUNDS INC00 0546,233Withhold
Invesco546,1250 00For
American Century174,5480 00For
SEI00 0117,724Withhold
Capitol Series Trust100,9000 00For
TARGET PORTFOLIO TRUST92,9000 00For
QUANTITATIVE MASTER SERIES LLC86,3970 00For
MASTER INVESTMENT PORTFOLIO86,3000 00For
State Street68,8450 06,313Mixed
Equitable9,5330 054,000Mixed
Prudential/PGIM62,1000 00For
Lincoln Financial00 050,355Withhold
AQR42,6730 00For
Northern Trust00 033,000Withhold
Fidelity27,0230 00For
AIG/SunAmerica25,6290 00For
Bridge Builder Trust21,1730 00For
Pacific Life20,0720 00For
New York Life14,0590 00For
Amplify ETF Trust13,3960 00For
John Hancock10,5770 02,676Mixed
Blackstone Alternative Investment Funds12,0000 00For

Showing the 25 largest of 47 asset managers. See all 47 in the interactive database.

3. Elect Director: Neal Fowler

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 4 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%
FOR: 23,476,806WITHHELD: 1,043,278
Details: description as filed, official tally, votes by 47 asset managers

Description as filed by funds: To elect three Class III directors to hold office for a term expiring at our 2027 Annual Meeting of Stockholders, each to serve and until their respective successors are duly elected and qualified: Neal Fowler

EMERGENT BIOSOLUTIONS INC.’s own tally for this item (“Elect Director: Neal Fowler”): 23,476,806 for, 1,043,278 withheld, per its Form 8-K filed May 29, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “All director nominees were elected and qualified.”
Support: 96% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 47 asset managers below reported 12,170,628 for.

FOR
FOR: 12,170,628
Largest asset managers voting on “To elect three Class III directors to hold office for a term expiring at our 2027 Annual Meeting of Stockholde” at EMERGENT BIOSOLUTIONS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Charles Schwab3,837,5400 00For
Vanguard3,245,0170 00For
BlackRock2,798,7020 00For
BRIDGEWAY FUNDS INC546,2330 00For
Invesco546,1250 00For
American Century174,5480 00For
SEI117,7240 00For
Capitol Series Trust100,9000 00For
TARGET PORTFOLIO TRUST92,9000 00For
QUANTITATIVE MASTER SERIES LLC86,3970 00For
MASTER INVESTMENT PORTFOLIO86,3000 00For
State Street75,1580 00For
Equitable63,5330 00For
Prudential/PGIM62,1000 00For
Lincoln Financial50,3550 00For
AQR42,6730 00For
Northern Trust33,0000 00For
Fidelity27,0230 00For
AIG/SunAmerica25,6290 00For
Bridge Builder Trust21,1730 00For
Pacific Life20,0720 00For
New York Life14,0590 00For
Amplify ETF Trust13,3960 00For
John Hancock13,2530 00For
Blackstone Alternative Investment Funds12,0000 00For

Showing the 25 largest of 47 asset managers. See all 47 in the interactive database.

4. To approve an amendment to the Emergent BioSolutions Inc. Amended and Restated Stock Incentive Plan.

No official matchCOMPENSATION

91% of fund votes cast · no official result

FOR
Details: votes by 47 asset managers

The 47 asset managers below reported 11,026,000 for, 1,043,812 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 11,026,000AGAINST: 1,043,812
Largest asset managers voting on “To approve an amendment to the Emergent BioSolutions Inc. Amended and Restated Stock Incentive Plan.” at EMERGENT BIOSOLUTIONS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Charles Schwab3,837,5400 00For
Vanguard3,245,0170 00For
BlackRock2,798,7020 00For
BRIDGEWAY FUNDS INC0546,233 00Against
Invesco546,1250 00For
American Century0174,548 00Against
SEI117,7240 00For
TARGET PORTFOLIO TRUST92,9000 00For
QUANTITATIVE MASTER SERIES LLC86,3970 00For
MASTER INVESTMENT PORTFOLIO86,3000 00For
State Street075,158 00Against
Equitable63,5330 00For
Prudential/PGIM62,1000 00For
Lincoln Financial050,355 00Against
AQR042,673 00Against
Northern Trust33,0000 00For
Fidelity1,83825,185 00Mixed
AIG/SunAmerica025,629 00Against
Bridge Builder Trust21,1730 00For
Pacific Life20,0720 00For
New York Life014,059 00Against
Amplify ETF Trust013,396 00Against
John Hancock013,253 00Against
Blackstone Alternative Investment Funds012,000 00Against
T. Rowe Price010,968 00Against

Showing the 25 largest of 47 asset managers. See all 47 in the interactive database.

5. To hold, on an advisory basis, a vote to approve the 2023 compensation of our named executive officers;

No official matchFund totals may overlapSECTION 14A SAY-ON-PAY VOTES

Combines 5 wordings of this item as funds reported it.

99.6% Fund and manager reports combined; may count the same shares twice · no official result

FOR
Details: votes by 154 asset managers

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports: 46 asset managers voting on “To hold, on an advisory basis, a vote to approve the 2023 compensation of our named executive officers;” at EMERGENT BIOSOLUTIONS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Charles Schwab3,837,5400 00For
Vanguard3,245,0170 00For
BlackRock2,798,7020 00For
BRIDGEWAY FUNDS INC546,2330 00For
Invesco546,1250 00For
American Century174,5480 00For
SEI117,7240 00For
TARGET PORTFOLIO TRUST92,9000 00For
QUANTITATIVE MASTER SERIES LLC86,3970 00For
MASTER INVESTMENT PORTFOLIO86,3000 00For
State Street75,1580 00For
Equitable63,5330 00For
Prudential/PGIM62,1000 00For
Lincoln Financial50,3550 00For
AQR42,6730 00For
Northern Trust33,0000 00For
Fidelity27,0230 00For
AIG/SunAmerica25,6290 00For
Bridge Builder Trust21,1730 00For
Pacific Life20,0720 00For
New York Life14,0590 00For
Amplify ETF Trust13,3960 00For
John Hancock13,2530 00For
Blackstone Alternative Investment Funds12,0000 00For
T. Rowe Price10,9680 00For

Fund voting reports, all 46 managers: 12,069,728 for. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 124 asset managers voting on “To hold, on an advisory basis, a vote to approve the 2023 compensation of our named executive officers;” at EMERGENT BIOSOLUTIONS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Charles Schwab3,837,5400 00For
BlackRock2,332,1090 00For
Avidity Partners Management LP1,448,8110 00For
State Street724,8740 00For
Connor, Clark & Lunn Investment Management Ltd.675,5610 00For
STRS OHIO604,7000 00For
BRIDGEWAY CAPITAL MANAGEMENT, LLC591,9330 00For
Invesco567,5890 00For
AQR309,9520 00For
PALISADE CAPITAL MANAGEMENT, LP265,3720 00For
Two Sigma232,7610 00For
Prudential/PGIM230,0100 00For
Northern Trust228,1570 00For
DE Shaw219,8120 00For
PARAMETRIC PORTFOLIO ASSOCIATES LLC210,1290 00For
American Century176,9800 00For
NEW YORK STATE COMMON RETIREMENT FUND153,4040 00For
FULLER & THALER ASSET MANAGEMENT, INC.139,8750 00For
Dimensional135,9110 00For
SEI121,4120 00For
TEACHER RETIREMENT SYSTEM OF TEXAS107,2630 00For
Allianz079,985 00Against
WHITTIER TRUST CO OF NEVADA INC75,0000 00For
MELLON INVESTMENTS Corp73,7030 00For
Goldman Sachs71,7840 00For

Institutional-manager reports, all 124 managers: 14,066,080 for, 97,341 against. Showing the 25 largest; see all in the interactive database.

6. To ratify the appointment by the audit and finance committee of Ernst & Young LLP as our independent registered public…

No official matchAUDIT-RELATED

Combines 2 wordings of this item as funds reported it.

99.8% of fund votes cast · no official result

FOR
Details: description as filed, votes by 46 asset managers

Description as filed by funds: To ratify the appointment by the audit and finance committee of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024;

The 46 asset managers below reported 12,056,332 for, 13,396 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 12,056,332AGAINST: 13,396
Largest asset managers voting on “To ratify the appointment by the audit and finance committee of Ernst & Young LLP as our independent registere” at EMERGENT BIOSOLUTIONS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Charles Schwab3,837,5400 00For
Vanguard3,245,0170 00For
BlackRock2,798,7020 00For
BRIDGEWAY FUNDS INC546,2330 00For
Invesco546,1250 00For
American Century174,5480 00For
SEI117,7240 00For
TARGET PORTFOLIO TRUST92,9000 00For
QUANTITATIVE MASTER SERIES LLC86,3970 00For
MASTER INVESTMENT PORTFOLIO86,3000 00For
State Street75,1580 00For
Equitable63,5330 00For
Prudential/PGIM62,1000 00For
Lincoln Financial50,3550 00For
AQR42,6730 00For
Northern Trust33,0000 00For
Fidelity27,0230 00For
AIG/SunAmerica25,6290 00For
Bridge Builder Trust21,1730 00For
Pacific Life20,0720 00For
New York Life14,0590 00For
Amplify ETF Trust013,396 00Against
John Hancock13,2530 00For
Blackstone Alternative Investment Funds12,0000 00For
T. Rowe Price10,9680 00For

Showing the 25 largest of 46 asset managers. See all 46 in the interactive database.

Largest EMERGENT BIOSOLUTIONS INC. shareholders voting in 2023-2024

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 52,400,000 shares outstanding at the time of that meeting.

Fund voting reports: top EMERGENT BIOSOLUTIONS INC. shareholders by shares voted on “To elect three Class III directors to hold office for a term expiring at our 2027 Annual…”, 2023-2024
#Asset manager % of shares outstanding
1Charles Schwab 7.32%
2Vanguard 6.19%
3BlackRock 5.34%
4BRIDGEWAY FUNDS INC 1.04%
5Invesco 1.04%
6American Century 0.33%
7SEI 0.22%
8Capitol Series Trust 0.19%
9TARGET PORTFOLIO TRUST 0.18%
10QUANTITATIVE MASTER SERIES LLC 0.16%
Institutional-manager reports: top EMERGENT BIOSOLUTIONS INC. shareholders by shares voted on “To hold, on an advisory basis, a vote to approve the 2023 compensation of our named executive…”, 2023-2024
#Asset manager % of shares outstanding
1Charles Schwab 7.32%
2BlackRock 4.45%
3Avidity Partners Management LP 2.76%
4State Street 1.38%
5Connor, Clark & Lunn Investment Management Ltd. 1.29%
6STRS OHIO 1.15%
7BRIDGEWAY CAPITAL MANAGEMENT, LLC 1.13%
8Invesco 1.08%
9AQR 0.59%
10PALISADE CAPITAL MANAGEMENT, LP 0.51%

Reported EMERGENT BIOSOLUTIONS INC. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

EMERGENT BIOSOLUTIONS INC. holdings and ownership disclosed for the 2023-2024 proxy season
Holder % outstanding Disclosure
BlackRock 8.14% 13F
Vanguard Group 6.76% 13F
Charles Schwab Investment Management, Inc. 5.48% DEF14A
Geode Capital 2.14% 13F
State Street 2.02% 13F
AQR Capital 2.01% 13F
Two Sigma 1.93% 13F
Millennium Management 1.71% 13F
Invesco 1.70% 13F
Renaissance Technologies 1.70% 13F

Percentages above are of 52,400,000 shares outstanding, as reported by EMERGENT BIOSOLUTIONS INC. on its Form 10-Q dated March 31, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from EMERGENT BIOSOLUTIONS INC.’s 10-Q dated March 31, 2024. This page is a static snapshot rebuilt weekly on October 13, 2026; a live search always shows the current data.

At EMERGENT BIOSOLUTIONS INC.'s shareholder meeting held May 23, 2024, in the 2023-2024 proxy season, 155 asset managers reported how they voted in their SEC Form N-PX filings, covering 934 separate fund positions. Their filings are grouped here into 6 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. EMERGENT BIOSOLUTIONS INC.'s own Form 8-K tally for this meeting is published below, but no row in it could be matched to the most widely held item, so this page states no certified outcome for that item. On that item — To hold, on an advisory basis, a vote to approve the 2023 compensation of our named executive… — the reporting funds and managers cast 99.6% of the shares they voted in favour (FOR divided by FOR plus AGAINST plus WITHHELD; abstained and unvoted shares are excluded because neither took a side). Fund and manager reports are combined in it and may count the same shares twice: it adds fund reports to institutional-manager reports, which can cover the same shares. It is not the company's certified result.

EMERGENT BIOSOLUTIONS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.

Download data (CSV): ballot items · votes by manager · column guide.